Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Isabelle Austin-Zimmerman"'
Autor:
Francisco Abad-Santos, Elvira Bramon, Antonio Metastasio, Anjali Bhat, Jasmine Harju-Seppänen, Johan H. Thygesen, Haritz Irizar, Mani Sairam, Maria Stella Calafato, Louise Marston, Eirini Zartaloudi, Isabelle Austin-Zimmerman
Publikováno v:
The Pharmacogenomics Journal. 20:629-637
Hyperprolactinemia is a known adverse drug reaction to antipsychotic treatment. Antipsychotic blood levels are influenced by cytochrome P450 enzymes, primarily CYP2D6. Variation in CYP450 genes may affect the risk of antipsychotic-induced hyperprolac
Autor:
Marta Wronska, Jasmine Harju-Seppänen, Johan H. Thygesen, Elvira Bramon, Karoline Kuchenbaecker, Anjali Bhat, Andrew McQuillin, Baihan Wang, Chris Finan, Spiros Denaxas, Eirini Zartaloudi, Isabelle Austin-Zimmerman, Olga Giannakopoulou, Ghazaleh Fatemifar, Haritz Irizar
Publikováno v:
Genes, Vol 12, Iss 1758, p 1758 (2021)
Genes
Volume 12
Issue 11
Genes
Volume 12
Issue 11
CYP2D6 and CYP2C19 enzymes are essential in the metabolism of antidepressants and antipsychotics. Genetic variation in these genes may increase risk of adverse drug reactions. Antidepressants and antipsychotics have previously been associated with ri
Autor:
Ghazaleh Fatemifar, Jasmine Harju-Seppänen, Marta Wronska, Baihan Wang, Elvira Bramon, Johan H. Thygesen, Eirini Zartaloudi, Isabelle Austin-Zimmerman, Haritz Irizar, Olga Giannakopoulou, Chris Finan, Anjali Bhat, Andrew McQuillin, Spiros Denaxas, Karoline Kuchenbaecker
BackgroundCYP2D6 and CYP2C19 enzymes are essential in the metabolism of antidepressants and antipsychotics. Genetic variation in these genes may increase risk of adverse drug reactions. Antidepressants and antipsychotics have previously been associat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72dc73b72be9d1bb2c399c0e12e90b17
https://doi.org/10.1101/2021.07.07.21259926
https://doi.org/10.1101/2021.07.07.21259926
Autor:
Eirini Zartaloudi, Isabelle Austin-Zimmerman, Yanisa Wannasuphoprasit, Anjali Bhat, Elvira Bramon, Dora Koller, Baihan Wang, Haritz Irizar
Publikováno v:
European Neuropsychopharmacology. 51:e131-e132
Autor:
Rick A. Adams, Heather Bruce, Karoline Kuchenbaecker, Ann Summerfelt, Oliver Pain, Jasmine Harju-Seppänen, Elvira Bramon, Karl J. Friston, Haritz Irizar, L. Elliot Hong, Deepak Srivastava, Rebecca Muir, Johan H. Thygesen, Anjali Bhat, Xiaoming Michael Du, Patricio O'Donnell, Eirini Zartaloudi, Isabelle Austin-Zimmerman, Baihan Wang, Mei-Hua Hall
Publikováno v:
Cell Reports
Summary Mismatch negativity (MMN) is a differential electrophysiological response measuring cortical adaptability to unpredictable stimuli. MMN is consistently attenuated in patients with psychosis. However, the genetics of MMN are uncharted, limitin
Autor:
Deepak Srivastava, Karl J. Friston, Patricio O'Donnell, Eirini Zartaloudi, Isabelle Austin-Zimmerman, Rick A. Adams, Elvira Bramon, Anjali Bhat, Johan H. Thygesen, Ann Summerfelt, L. Elliot Hong, Xiaoming Michael Du, Rebecca Muir, Baihan Wang, Oliver Pain, Jasmine Harju-Seppänen, Heather Bruce, Mei-Hua Hall, Karoline Kuchenbaecker, Haritz Irizar
Publikováno v:
SSRN Electronic Journal.
Mismatch negativity (MMN) is a differential electrophysiological response measuring cortical adaptability to unpredictable stimuli. MMN is consistently attenuated in patients with psychosis. However, the genetics of MMN are uncharted, limiting the va
Autor:
Elvira Bramon, Anjali Bhat, Johan H. Thygesen, Stella Calafato, Haritz Irizar, Eirini Zartaloudi, Isabelle Austin-Zimmerman, Jasmine Harju-Seppänen
Publikováno v:
European Neuropsychopharmacology. 29:S1169